DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Precedex (Dexmedetomidine Hydrochloride) - Summary

 
 



PRECEDEX SUMMARY

Precedex (dexmedetomidine hydrochloride injection) is a sterile, nonpyrogenic solution suitable for intravenous infusion following dilution. Dexmedetomidine hydrochloride is the S-enantiomer of medetomidine and is chemically described as (+)-4-(S)-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole monohydrochloride.

Intensive Care Unit Sedation

Precedex is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. Precedex should be administered by continuous infusion not to exceed 24 hours.

Precedex has been continuously infused in mechanically ventilated patients prior to extubation, during extubation, and post-extubation. It is not necessary to discontinue Precedex prior to extubation.

Procedural Sedation

Precedex is indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures.


See all Precedex indications & dosage >>

NEWS HIGHLIGHTS

Media Articles Related to Precedex (Dexmedetomidine)

Pain relief for kids in the ER without a needle
Source: Pain / Anesthetics News From Medical News Today [2014.12.08]
Children in emergency departments can safely be treated for pain from limb injuries using intranasal ketamine, a drug more typically used for sedation, according to the results of the first...

more news >>

Published Studies Related to Precedex (Dexmedetomidine)

Comparison of dexmedetomidine and propofol for conscious sedation in awake craniotomy: a prospective, double-blind, randomized, and controlled clinical trial. [2013]
sedation in awake craniotomy... CONCLUSIONS: Either DEX or PRO can be effectively and safely used for conscious

Effect of dexmedetomidine on plasma brain-derived neurotrophic factor: A double-blind, randomized and placebo-controlled study. [2013]
CONCLUSION: It appears that DEX could reverse the reduced plasma concentrations

Perioperative infusion of dexmedetomidine at a high dose reduces postoperative analgesic requirements: a randomized control trial. [2011.09.28]
PURPOSE: We hypothesized that a high dose of dexmedetomidine (1 mug/kg/h) could reduce postoperative analgesic requirements of patients... CONCLUSIONS: Among this small patient cohort, perioperative infusion of dexmedetomidine (1 mug/kg/h) resulted in antinociception without severe side effects. These results suggest that this method could be of interest with respect to improving postoperative pain status.

A randomized, blinded, controlled trial of the antiemetic effect of ondansetron on dexmedetomidine-induced emesis in cats. [2011.07]
OBJECTIVE: To determine the effect of ondansetron on the incidence of vomiting in cats pre-medicated with dexmedetomidine and buprenorphine.

Dexmedetomidine as a pediatric anesthetic premedication to reduce anxiety and to deter emergence delirium. [2011.06]
Presurgery anxiety in children may result in preoperative and postoperative complications...

more studies >>

Clinical Trials Related to Precedex (Dexmedetomidine)

Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy Surgery [Not yet recruiting]
Primary Hypothesis: The use of a Precedex infusion, in addition to propofol during surgery, will improve patient management through the anesthesia postoperative recovery period determined by improvement in patients? tolerance of the endotracheal tube.

Secondary hypothesis: The use of a Precedex infusion, in addition to propofol during surgery will provide improved hemodynamic stability.

Awake Intubation - Precedex Used for Sedation During Elective Awake Fiberoptic Intubation [Active, not recruiting]
The objective of this study is to evaluate the safety and efficacy of dexmedetomidine versus placebo used for sedation during elective awake fiberoptic intubation.

Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal [Not yet recruiting]
This study is designed to evaluate dexmedetomidine as adjunctive therapy of severe alcohol withdrawal of medical ICU patients. Specifically, this study will assess whether adjunctive dexmedetomidine reduces the doses of conventional agents used for alcohol withdrawal while maintaining patient comfort and safety and will explore if dexmedetomidine exhibits a dose-dependent profile of action when it is used for this indication. In addition, this study will assess the relationships between alcohol withdrawal, therapy with dexmedetomidine, and potential serum biomarkers of alcohol withdrawal.

Intraoperative Infusion of Precedex to Reduce Length of Stay After Lumbar Spine Fusion [Recruiting]
Major lumbar spine surgery causes inflammation, soreness and swelling that can delay discharge from the hospital. Dexmedetomidine (DEX) has been shown to have anti-inflammatory effects. This study will evaluate whether DEX can help get patients out of the hospital faster after major spine surgery by reducing the inflammation associated with the procedure itself. A separate part of the study will evaluate the blood levels of some specific indicators of inflammation called cytokines. Measuring cytokines before and after surgery will aid in determining if DEX has altered the inflammatory response.

Dexmedetomidine in Seizure Patients [Recruiting]
Dexmedetomidine is an alpha-2 agonist commonly used during neurosurgery due to its unique properties as a sedative and anxiolytic with minimal respiratory depression. Neurosurgical patients frequently come to the operating room on anticonvulsant therapy with a history of seizures. The investigators clinical experience suggests that these patients are resistant to the sedative effects of dexmedetomidine. This effect may represent a pharmacokinetic interaction between the anticonvulsant medications and dexmedetomidine or the higher dexmedetomidine dose requirement could result from abnormal pharmacodynamics due to the underlying seizure disorder. The investigators study aims to investigate the pharmacokinetic and pharmacodynamic differences of dexmedetomidine between patients receiving and not receiving enzyme-inducing anticonvulsant therapy and to identify a potential mechanism for these differences.

more trials >>

Reports of Suspected Precedex (Dexmedetomidine) Side Effects

Cardiac Arrest (6)Bradycardia (5)Procedural Complication (4)Agitation (3)Hyperthermia (3)Musculoskeletal Stiffness (3)Blood Creatine Phosphokinase Increased (2)Acidosis (2)Hepatitis Fulminant (2)Peripheral Circulatory Failure (2)more >>


Page last updated: 2014-12-08

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014